GASTROENTEROPANCREATIC NEUROENDOCRINE NEOPLASM

Clinical trials for GASTROENTEROPANCREATIC NEUROENDOCRINE NEOPLASM explained in plain language.

Never miss a new study

Get alerted when new GASTROENTEROPANCREATIC NEUROENDOCRINE NEOPLASM trials appear

Sign up with your email to follow new studies for GASTROENTEROPANCREATIC NEUROENDOCRINE NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

Radioactive drug tested to stop Cancer's return after liver surgery

Disease control Terminated

This study tested whether giving Lutathera, a targeted radioactive drug, after surgery to remove neuroendocrine tumor spread in the liver could prevent the cancer from coming back. It compared this treatment against standard monitoring and supportive care in patients whose primar…

Matched conditions: GASTROENTEROPANCREATIC NEUROENDOCRINE NEOPLASM

Phase: PHASE2 • Sponsor: Imperial College London • Aim: Disease control

Last updated Mar 31, 2026 12:12 UTC

GASTROENTEROPANCREATIC NEUROENDOCRINE NEOPLASM

Get alerted when new GASTROENTEROPANCREATIC NEUROENDOCRINE NEOPLASM trials appear

Radioactive drug tested to stop Cancer's return after liver surgery